UNSPSC 51343503: Tenofovir

This classification denotes a reverse transcriptase inhibitor and purine antagonist with the molecular formula C9H14N5O4P.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99YXE507IL, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, (r)- but generally known as tenofovir, which bears US NIH Compound Identifier 464205. European Medicines Agency schedules Tenofovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04721MIG.

Most nations schedule tenofovir under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR remains the US FDA Preferred Term for this commodity. Tenofovir bears US NLM identifiers UMLS ID C0384228 and NCI Concept Code C29490. SMILES: P(=O)(O)(O)COC(Cn1c2ncnc(N)c2nc1)C.

UNSPSC 51343503 Tenofovir is a Commodity code that in recent state and local solicitations covers pharmaceutical supply and emergency medical consumables procurement — a category substantially broader than the code's specific antiviral-drug name suggests. State and local buyers under this code are acquiring naloxone and drug deactivation systems, generic pharmaceuticals through cooperative purchasing alliances, and medical and first aid supplies for emergency response divisions. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing organizations. Recent activity shows a mix of traditional sealed-bid procurements, requests for information gathering on direct-to-manufacturer contracting models, and cooperative purchasing vehicle awards that bundle manufacturers into state and multi-state supply chains.

Activity appears concentrated in Florida and the Upper Midwest. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries and a two-year initial term plus one-year renewal option. The City of Tampa issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, an estimated $700,000 procurement sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration, administering the multi-state MMCAP cooperative purchasing program, solicited manufacturers of generic multi-source pharmaceuticals and OTC products in January 2026 with a March 26 response deadline, effective July 1, 2026, across participating state and local facilities including Oregon. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to explore vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling potential future formal solicitations but no immediate contract awards. The code shows active procurement across emergency response, public health, and pharmacy benefit management functions, though the mismatch between the code's nominal scope and the actual work being bought merits close attention in vendor outreach.